09995 榮昌生物
公司背景| 業務概覽| 企業架構| 基本數據| 財務比率| 損益表| 財務狀況表| 現金流量表| 派息紀錄| 盈利預測| 股權變動| 股票賣空
公司資料 - 財務比率
榮昌生物製藥（煙台）股份有限公司 股票編號： 09995
REMEGEN CO., LTD. 集團網址： http://www.remegen.com
盈利能力分析
2023/12 2022/12 2021/12 2020/12 2019/12
資產回報率 (%)-26.170%-19.623%6.675%-29.034%-70.514%
股東資金回報率 (%)-35.907%-23.706%7.847%-41.504%N/A
資本運用回報率 (%)-34.419%-19.475%7.798%-18.930%N/A
 
邊際利潤分析
毛利率 (%)76.477%64.841%95.283%N/AN/A
未計利息、稅項、折舊及攤銷前利潤率 (%)-140.897%-112.899%25.215%N/AN/A
稅前邊際利潤率 (%)-140.432%-130.094%19.401%N/AN/A
純利率 (%)-140.432%-130.094%19.401%N/AN/A
 
變現能力分析
流動比率 (X)1.959 X3.600 X3.731 X6.903 X0.161 X
速動比率 (X)1.308 X3.014 X3.276 X6.750 X0.124 X
 
財務槓桿分析
總負債 / 總資產比率 (%)37.823%17.287%17.138%12.703%133.652%
總負債 / 股東資金比率 (%)60.832%20.900%20.682%14.551%N/A
非流動負債 / 股東資金比率 (%)27.738%2.984%2.797%2.553%N/A
利息盈利率 (倍)N/AN/A52.899 XN/AN/A
 
營運效率分析
存貨周轉率日數 (日)214.400 Day(s)190.870 Day(s)44.413 Day(s)N/AN/A
 

Copyright © 2024 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.